Mission Raises $15m and Expands its Relationship with Pfizer CAMBRIDGE, UK– 6 July 2020 – Mission Therapeutics (“Mission”), a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), today announced that it has raised $15m (£12Read More
BotsAndUs secures $6m, to continue its mission to bring autonomous robotics into everyday environments BotsAndUs’ autonomous robotics solutions are designed for indoor, dynamic, public spaces. They are the engine for real-time data that automates customer Read More